News

November 13, 2008 - Medtronic Inc. today started its U.S. market launch of the Endeavor Sprint drug-eluting stent (DES) on a rapid exchange (RX) delivery system.

October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.

October 27, 2008 - Boston Scientific Corp. last week said the FDA approved its Carotid WALLSTENT Monorail Endoprosthesis for the treatment of patients with carotid artery disease who are at high...

October 20, 2008 – At TCT last week Abbott announced two-year data from 30 patients in its ABSORB clinical trial, demonstrating its bioabsorbable drug eluting stent successfully treated coronary...

October 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System and the company plans to...

September 11, 2008 -Cook Medical has completed enrollment in the first international clinical trial of a first-of-its-kind drug-eluting stent designed to treat arterial blockages outside the...

July 17, 2008 - MIV Therapeutics Inc. today said its Protea ultra-thin cobalt-alloy bare metal stent has excelled in animal studies, reportedly showing the Protea is statistically superior to one...

June 12, 2008 – The registry arm of a clinical study to assess the safety and effectiveness of Cook Medical’s Zilver PTX Drug-Eluting Peripheral Stent (DES) in treating peripheral arterial disease...

June 3, 2008 - The CE certified Over and Under Pericardium Covered Stent (PCS) commercial implantation and first implantation in the U.K. was performed at the Royal Bournemouth Hospital,...

May 30, 2008 - Three patients with established cardiac ischemia recently became the first recipients of the vProtect Luminal Shield, a self-expanding intracoronary prosthesis designed to limit...